Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AerBetic is a private U.S. health technology company developing non-invasive wearable devices for diabetes monitoring. Its core product concept uses nanotechnology-based gas sensors embedded in wearables such as bracelets or pendants to detect breath- and skin-emitted gases associated with hypoglycemic and hyperglycemic episodes. The system is paired with a mobile app that provides alerts and remote monitoring for patients and caregivers. AerBetic positions its technology as an alternative to painful or cumbersome glucose monitoring approaches, inspired by the ability of diabetic alert dogs to detect metabolic changes by smell. The company appears to be in an early commercial-development stage, with public materials emphasizing beta testing and a "coming soon" product rather than marketed devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AerBetic.